Back to Search Start Over

Amelioration of Early Radiation Effects in Oral Mucosa (Mouse) by Intravenous or Subcutaneous Administration of Amifostine

Authors :
Fleischer, Gabriele
Dörr, Wolfgang
Source :
Strahlentherapie und Onkologie; October 2006, Vol. 182 Issue: 10 p567-575, 9p
Publication Year :
2006

Abstract

Purpose:: To quantify the reduction of radiation-induced oral mucositis by amifostine as a function of administration route.Material and Methods:: Mucosal ulceration of lower mouse tongue epithelium was analyzed. Amifostine was injected at 1.8 mg/injection subcutaneously (s.c.) or intravenously (i.v.), 45 min or 10 min prior to irradiation. With single-dose irradiation, a single amifostine injection was given. During daily fractionated irradiation (5 3 Gy) for 1 week, amifostine was administered s.c. or i.v. twice (days 0, 3), or s.c. on all irradiation days (days 0–4). With ten fractions over 2 weeks, five s.c. injections were given in week 1 (days 0–4) or week 2 (days 7–11), or both. Two i.v. injections were given either in week 1 (days 0, 3) or week 2 (days 7, 10). All fractionation protocols were terminated by graded test doses to generate full dose-effect curves.Results:: In a single-dose control experiment, the ED<subscript>50</subscript>(dose after which ulcer induction is expected in 50% of the mice) was 11.7 1.4 Gy. Intravenous application of amifostine increased the ED<subscript>50</subscript>to 14.0 1.4 Gy (p = 0.024), while s.c. administration had no significant effect. The ED<subscript>50</subscript>for test irradiation after 5 3 Gy was 5.8 1.4 Gy. Two s.c. or i.v. amifostine injections yielded ED<subscript>50</subscript>values of 7.2 1.1 Gy (p = 0.0984) or 7.6 1.2 Gy (p = 0.0334); five s.c. injections increased the ED<subscript>50</subscript>to 8.2 0.9 Gy (p = 0.0039). The ED<subscript>50</subscript>after 10 3 Gy/2 weeks was 6.6 1.8 Gy. Subcutaneous or intravenous administration of amifostine in week 1 yielded a significant increase in ED<subscript>50</subscript>to 9.4 2.5 Gy (p = 0.0099) and 10.0 2.2 Gy (p = 0.0014). By contrast, amifostine administration in week 2 had no significant effect. Administration in weeks 1 and 2 resulted in an ED<subscript>50</subscript>of 10.8 3.6 Gy (p = 0.0053).Conclusion:: Amifostine during daily fractionated irradiation is effective only if administered in the initial treatment phase, i.e., week 1 in the mouse. The differences in the effect in weeks 1 and 2 suggest mechanisms of action other than radical scavenging.

Details

Language :
English
ISSN :
01797158 and 1439099X
Volume :
182
Issue :
10
Database :
Supplemental Index
Journal :
Strahlentherapie und Onkologie
Publication Type :
Periodical
Accession number :
ejs10707342
Full Text :
https://doi.org/10.1007/s00066-006-1587-8